US Regulator Approves Pfizer’s RSV Vaccine for Adults 60 and Older
The U.S. Food and Drug Administration (FDA) on Wednesday approved Pfizer Inc.'s respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors. The approval comes less than a month after the…